期刊文献+

卵巢上皮性肿瘤的声像图特点与其肿瘤标志物定量的相关性研究 被引量:1

The correlation study of transvaginal ultrasound characteristics and serum tumor markers in epithelial ovarian carcinoma
下载PDF
导出
摘要 目的探讨卵巢上皮性肿瘤声像图特点与血清肿瘤标志物的相关性。方法对136例卵巢上皮性肿瘤患者的经阴道超声的二维声像图、血流信号强度和肿瘤内径3个指标分级,分析其与肿瘤标志物血清癌胚抗原(CA125)、骨桥蛋白(OPN)、恶性肿瘤特异性生长因子(TSGF)、溶血磷脂酸(LPA)的相关性。结果四项血清肿瘤标志物水平随超声信息分级的升高而增加,呈正相关(P〈0.01)。二维声像图与CA125、LPA呈高度相关(rs〉0.8),与OPN和TSGF呈中度相关(L〉0.6);血流信号强度与LPA呈高度相关(rs〉0.8),与CA125、OPN、TSGF呈中度相关(rs〉0.4);肿瘤内径与LPA呈高度相关(rs〉0.8),与CA125呈中度相关(rs〉0.6),与OPN和TSGF呈低度相关(rs〈0.4)。结论超声检查结合LPA、CA125的检测可能较结合OPN、TSG的检测,对卵巢上皮性肿瘤严重程度的判定更具特异性。 Objective To study the relationship between transvaginal ultrasound information and serum tumor markers of epithelial ovarian carcinoma. Methods The data of transvaginal ultrasound information and serum tumor markers in 136 patients with epithelial ovarian carcinoma were retrospectively analyzed. Ultrasound information was divided into 3 indexes, including sonogram, bloodstream signal- gram and tumor inner diameter, then the relationship between indexes and serum tumor markers was analyzed. Results There was positive correlation between transvaginal ultrasound information and serum tumor markers ( P 〈 0.01 ) ; In sonograms, the correlation between indexes of CA125 and LPA was high ( rs 〉 0.8 ), OPN and TSGF was moderate ( rs〉 O. 6); In bloodstream signal - gram, the correlation of index of LPA was high( rs 〉 0.8), CA125, OPN and TSGF were moderate( rs 〉 0.4) ; In tumor inner-diameter, the correlation of index of LPA was high( rs〉 0.8), CA125 was moderate( rs 〉 0.6), OPN and TSGF was lower( rs〈 0.4). Conclusion Transvaginal ultrasonography combined with CA125 and LPA is more specific than combined with OPN and TSGF in diagnosing epithelial ovarian carcinoma.
出处 《临床超声医学杂志》 2009年第1期27-29,共3页 Journal of Clinical Ultrasound in Medicine
关键词 超声检查 经阴道 肿瘤标志物 相关性 Ultrasonography, transvaginal Tumor markers Correlation
  • 相关文献

参考文献9

  • 1Timmerman D, Valentin L, Bourne TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol, 2000,16(5):395- 398.
  • 2Valentin L, Ameye L, Testa A, et al. Uhrasound characteristics of different types of adnexal malignancies. Gynecologic Oncology, 2006, 102(1) :41 - 48.
  • 3Coppola D, Szabo M, Boulware D, et al. Correlation of osteopotin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res,2004,10(1 pt 1) : 184 - 190.
  • 4Koopmann J, Fedarko NS, Jain A, et al. Evaluation of osteopotin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prey, 2004,13(3) :487 - 491.
  • 5Hu YL, Albanese C, Pestell RG, et al. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J Nad Cancer Inst, 2003,95 (10) : 733 - 740.
  • 6Fishman DA, Liu Y, Ellerbroek SM, et al. Lysophosphatidic acid promotes lnatrix metalloproteinase (MMP) activation and MMP- dependent invasion in ovarian cancer cells. Cancer Res, 2001, 61 (7): 3194 - 3199.
  • 7马小玲,张玉泉.骨桥蛋白与卵巢上皮性癌关系的研究进展[J].中华妇产科杂志,2006,41(7):495-497. 被引量:6
  • 8曾辉,裴小青,郑丹苗,赵雁梨,陈孝岳.经阴道彩色多普勒超声检查联合血清CA125检测监测卵巢癌术后复发[J].癌症,2006,25(10):1296-1299. 被引量:7
  • 9胡越,陈小知,蔡莲莲,温怀凯,吕夕明,孙静.经阴道超声彩色多普勒及肿瘤标记物诊断卵巢癌的价值[J].中国超声医学杂志,2003,19(11):859-862. 被引量:9

二级参考文献31

  • 1李孟达,李玉洁,黄永文,黄鹤.影响上皮性卵巢癌远期疗效的因素分析[J].癌症,2004,23(11):1306-1310. 被引量:19
  • 2Fedarko NS, Jain A, Karadag A, et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res, 2001, 7:4060-4066.
  • 3Wong TS, Kwong DL, Sham J, et al. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma. Eur J Surg Oncol, 2005, 31:555-558.
  • 4Ang C, Chambers AF, Tuck AB, et al. Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder. BJU Int, 2005, 96:803-805.
  • 5Boldrini L, Donati V, Dell' Omodarme M, et al. Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer. Br J Cancer, 2005, 93:453-457.
  • 6Rosen DG, Wang L, Atkinson jN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer.Gynecol Oncol, 2005, 99:267-277.
  • 7Maki M, Hirota S, Kaneko Y, et al. Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: a possible association with calcification of psammoma bodies. Pathol Int, 2000, 50:531-535.
  • 8Fisher LW, Jain A, Tayback M, et aL Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.Clin Cancer Res, 2004, 10:8501-8511.
  • 9O'Neill CJ, Deavers Mr, Malpica A, et al. An immuno-histochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p.53, MIB1,BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. Am J Surg Pathol, 2005, 29 : 1034-1041.
  • 10Mills GB, Bast RC Jr, Srivastava S. Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics. J Nail Cancer Inst, 2001,93 : 1458-1464.

共引文献16

同被引文献8

  • 1Tjalma W, Van Marck E, Weyler J ,et al.Quantification and prognostic relevance of angiogenic parameters ininvasive cevical cancer. Br J Cancer, 1998,78 (2) : 170 - 174.
  • 2Bremer GL, Tiebosch AT, van der Putten HW, et al. Tumor angiogenesis: an independent prognosticparameter in cervical cancer. Am J Obstet Gynecol,1996,17(1pt 1) :126 - 131.
  • 3Alcazar JL,Galan MJ ,Jurado M ,et al. Intratumoral blood flow analysis in endometrial carcinoma:correlation with tumor characteristics and risk for recurrence. Gynecol Oncol,2002,84(2) :258 -262.
  • 4Kidron D, Bernheim J, Aviram R, et al. Resistance to blood flow in ovarian tumors : correlation between resistance index and histological pattern of vascularization. Ultrasound Obstet Gynecol, 1999,13 (6) : 425 - 430.
  • 5Hao L,Chan C, Eng H,et al. The role of pretreatment squamous cell carcinoma antigen in predicting nodalmetastasis in early stage cervical cancer. Acta Obstet Gynecol Scand ,2000,79 ( 2 ) : 140 - 144.
  • 6Maiman M. The clinical application of serum squamous cell carcinoma antigen level monitoring in invasive cervical carcinoma. Gynecol Onco1,2002,841 ( 1 ) :4 -6,.
  • 7杨健,陈增良.血管新生与肿瘤生长的研究进展[J].浙江大学学报(医学版),2001,30(4):189-192. 被引量:6
  • 8谢红宁,李丽娟,孔秋英,蔡文,郭念群.卵巢恶性肿瘤超声血流指标与微血管密度的相关性研究[J].中国实用妇科与产科杂志,2002,18(9):553-554. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部